Efebera, Yvonne A <br/><br/>
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT).  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Jan 2016 
 - 71-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2015.07.034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Allografts<br/>Atorvastatin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Graft vs Host Disease--etiology<br/>Hematopoietic Stem Cell Transplantation<br/>Histocompatibility Testing<br/>Humans<br/>Male<br/>Middle Aged<br/>Survival Rate<br/>Tissue Donors